VMVIX
Price
$65.67
Change
+$0.51 (+0.78%)
Updated
Jul 17 closing price
Net Assets
30.57B
WFPAX
Price
$47.28
Change
+$0.33 (+0.70%)
Updated
Jul 17 closing price
Net Assets
13.09B
Interact to see
Advertisement

VMVIX vs WFPAX

Header iconVMVIX vs WFPAX Comparison
Open Charts VMVIX vs WFPAXBanner chart's image
Vanguard Mid-Cap Value Index Investor
Price$65.67
Change+$0.51 (+0.78%)
VolumeN/A
Net Assets30.57B
Allspring Special Mid Cap Value A
Price$47.28
Change+$0.33 (+0.70%)
VolumeN/A
Net Assets13.09B
VMVIX vs WFPAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
VMVIX vs. WFPAX commentary
Jul 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is VMVIX is a Buy and WFPAX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VMVIX has more cash in the bank: 30.6B vs. WFPAX (13.1B). VMVIX pays higher dividends than WFPAX: VMVIX (2.14) vs WFPAX (0.97). VMVIX was incepted earlier than WFPAX: VMVIX (19 years) vs WFPAX (18 years). WFPAX (1.12) is less costly to investors than VMVIX (0.19). VMVIX (19.00) and WFPAX (19.00) have comparable annual turnover. WFPAX has a lower initial minimum investment than VMVIX: WFPAX (1000) vs VMVIX (3000). VMVIX annual gain was more profitable for investors over the last year : 4.95 vs. WFPAX (-4.23). VMVIX return over 5 years is better than : 67.64 vs. WFPAX (39.31).
VMVIXWFPAXVMVIX / WFPAX
Total Expense Ratio0.191.1217%
Annual Report Gross Expense Ratio0.191.1217%
Fund Existence19 years18 years-
Gain YTD2.3802.065115%
Front LoadN/A6%-
Min. Initial Investment30001000300%
Min. Initial Investment IRAN/AN/A-
Net Assets30.6B13.1B234%
Annual Yield % from dividends2.140.97221%
Returns for 1 year4.95-4.23-117%
Returns for 3 years27.9311.00254%
Returns for 5 years67.6439.31172%
Returns for 10 years85.7250.64169%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PVLA31.232.81
+9.89%
Palvella Therapeutics Inc
TDACU10.43N/A
N/A
Translational Development Acquisition Corp
ALSN88.92-0.13
-0.15%
Allison Transmission Holdings
EXPI10.19-0.12
-1.16%
eXp World Holdings
NVNI0.34-0.01
-4.12%
Nvni Group Limited